Clinical guidelines for primary sclerosing cholangitis 2017

PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group

Research output: Contribution to journalReview articlepeer-review

54 Citations (Scopus)


Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC. Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA. Results: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart. Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.

Original languageEnglish
Pages (from-to)1006-1034
Number of pages29
JournalJournal of Gastroenterology
Issue number9
Publication statusPublished - 01-09-2018

All Science Journal Classification (ASJC) codes

  • Gastroenterology


Dive into the research topics of 'Clinical guidelines for primary sclerosing cholangitis 2017'. Together they form a unique fingerprint.

Cite this